Rexnord to slash debt after quarterly loss
Rexnord Corp., a manufacturer of motion technology products for the aersospace, construction, and energy industries, will begin to slash its debt after reporting a quarterly loss of $2.8 million....
Rexnord Corp., a manufacturer of motion technology products for the aersospace, construction, and energy industries, will begin to slash its debt after reporting a quarterly loss of $2.8 million....
The University Clinic Heidelberg will be the first of four German university hospitals to treat cancer patients with TomoTherapy's Hi-Art System as the Madison-based medical device manufacturer extends its market reach into the Deutschland. ...
The business community needs to be more actively involved in determining the future of electronics recycling policy in Wisconsin, which must benefit both business and the environment, says Neil-Peters-Michaud, chief executive of a Madison-based electronics recycling company. The alternative? Leave it entirely up to the...
Inventors may or may not pay a price for being tardy in patenting their inventions, but they are better off not leaving things to chance. In this opinion piece, Chicago attorneys Bratislav Stankovic and Donald Silvert say it's wise to heed recent judicial interpretations of...
Wisconsin Technical College professors gathered at Madison Area Technical College this month for an IT boot camp designed to help them keep pace with technological advancements. Their test will come in the classroom this fall when they attempt to apply what they've learned....
TDS Telecom is on a "Vishing" expedition to nab a company engaged in unethical marketing practices. The company is warning customers not to be fooled by discount offers designed to capture their personal information....
A new legal challenge to stem cell patents held by the Wisconsin Alumni Research Foundation will trace the history of stem cell development, which critics say predates the work of UW researcher James Thomson. WARF, armed with a $1.5 billion endowment, is promising a vigorous...
The federal government will continue to draw lines around human embryonic stem cell research following President Bush's veto of the Stem Cell Research Enhancement Act. The House of Representatives fell well short of the two-thirds required to override....
The United States Senate, defying the threat of a presidential veto, voted overwhelmingly to modify President Bush's ban on new federal funding for embryonic stem cell research. However, the 63 votes in favor of a less restrictive policy is not enough to override a promised...
Imagine, for a moment, that you're a Wisconsin life sciences company and you have a sales rep in biotech hotbeds like San Francisco or Boston. Sound like a dream? Madison's NeoClone is trying to see if it can become a reality with the help of...